Showing results (31-40 of 300) with videos related to
Sort By:
Pageof 30
Current Opinion in Pharmacology|April 30, 2017
New biologics in the treatment of rare glomerular diseases of childhoodPaolo Cravedi, Andrea Angeletti, Giuseppe RemuzziPediatric Nephrology (Berlin, Germany)|April 18, 2026
B-cell-targeting therapies in podocytopathiesCarolina Bigatti, Paolo Cravedi, Andrea AngelettiExpert Opinion on Pharmacotherapy|October 28, 2010
Which antihypertensive drugs are the most nephroprotective and why?Paolo Cravedi, Piero Ruggenenti, Giuseppe RemuzziNature Reviews. Nephrology|May 5, 2010
The RAAS in the pathogenesis and treatment of diabetic nephropathyPiero Ruggenenti, Paolo Cravedi, Giuseppe RemuzziCurrent Hypertension Reports|January 8, 2008
Intensified inhibition of renin-angiotensin system: a way to improve renal protection?Paolo Cravedi, Piero Ruggenenti, Giuseppe RemuzziSeminars in Dialysis|June 21, 2011
Targeting the renin angiotensin system in dialysis patientsPaolo Cravedi, Giuseppe Remuzzi, Piero RuggenentiExpert Opinion on Pharmacotherapy|November 27, 2007
Latest treatment strategies for membranous nephropathyPiero Ruggenenti, Paolo Cravedi, Giuseppe RemuzziCurrent Hypertension Reports|March 13, 2009
Intensified inhibition of renin-angiotensin system: a way to improve renal protection?Paolo Cravedi, Piero Ruggenenti, Giuseppe RemuzziNature Reviews. Nephrology|June 27, 2009
Proteinuria: Increased angiotensin-receptor blocking is not the first optionPiero Ruggenenti, Paolo Cravedi, Giuseppe RemuzziKidney International. Supplement|December 1, 2010
Non-immune interventions to protect kidney allografts in the long termPaolo Cravedi, Norberto Perico, Giuseppe RemuzziPageof 30